MabGenesis Inc. announced that it has received ¥330 million in an equity round of funding on December 2, 2022. The transaction included participation from Kibou Investment Limited Partnership, a fund managed by, Yokohama Capital Co. Ltd., Vector Inc., new investors, Kyushu Kouiki Fukkou Shien Fund, a fund managed by REVIC Capital Co., Ltd. and Long Black Partners Co.,Ltd., Investment Arm.

The method of capital increase was through third party allotment.